11 Overstated
Sitting still and breathing consumes approximately 3 ml/kg/min of oxygen, while speaking in conversation consumes approximately 11 ml/kg/min.
"Just to sit still and breathe, it takes about 3 ml per kilogram per minute of oxygen. When I'm just having a conversation, like me up here on stage talking to you guys, that takes about 11 ml per kilogram body weight per minute of oxygen, right?" (said at 0:05:02)
Standard resting metabolic rate (1 MET) is established in exercise physiology as approximately 3.5 ml/kg/min of oxygen consumption (VO2). However, claiming that conversational speech consumes approximately 11 ml/kg/min (over 3 METs) substantially overstates the metabolic cost of talking. In standard physical activity classifications, talking while seated or standing is classified as a sedentary to light-intensity activity (typically ~1.3 to 1.8 METs, or approximately 4.5 to 6.3 ml/kg/min). An oxygen uptake of 11 ml/kg/min corresponds to moderate-intensity physical exertion, such as brisk walking.
Lactate signals the brain to increase serotonin and norepinephrine production in humans in a dose-dependent manner based on exercise intensity.
"We also know that lactate itself signals to the brain to make neurotransmitters. We have human data on this, both serotonin... And norepinephrine as well." (said at 0:18:59)
Preclinical animal and in vitro research demonstrates that L-lactate can act as a signaling molecule in the brain (for example, exciting locus coeruleus neurons to stimulate norepinephrine release). However, direct evidence establishing that lactate itself acts as a signaling molecule to stimulate both serotonin and norepinephrine production in the human brain in a dose-dependent manner during exercise is lacking. Claiming that there is direct human data confirming lactate-driven production of both serotonin and norepinephrine overstates preclinical animal models.
Performing 30 bodyweight squats every 45 minutes across a 7.5-hour workday improves glucose metabolism more than a single 30-minute continuous walk.
"There was this recent study that came out showing that doing about 30 body weight squats every 45 minutes for like a 7 and 1/2-hour workday was better at improving glucose metabolism than a 30-minute walk." (said at 0:24:38)
The statement misrepresents the protocol and comparison group of the relevant randomized crossover trial (PMID 33180640). In that 7.5-hour laboratory trial, 14 healthy young adults performed 15 bodyweight chair stands (with calf raises) every 30 minutes—not 30 squats every 45 minutes. The comparison intervention was intermittent walking (2 minutes of walking every 30 minutes across the 7.5-hour day, accumulating 28–30 minutes total), rather than a single continuous 30-minute walk. The study found that intermittent squats lowered 3-hour post-lunch insulin incremental area under the curve (iAUC) by 24% and insulin:glucose iAUC by 30% compared with uninterrupted sitting, while intermittent walking lowered insulin:glucose iAUC by 23%; blood glucose concentrations did not differ significantly between conditions.
- partial: Interrupting prolonged sitting with repeated chair stands or short walks reduces postprand… (Journal of applied physiology (Bethesda, Md. : 1985) 2021) · cited 29x in the literature
"Fourteen participants (7 males, 7 females; 24 ± 5 yr; 25 ± 5 kg/m2; 40 ± 8 mL/kg/min; 7,033 ± 2,288 steps/day) completed three 7.5-h trials in a randomized order consisting of uninterrupted sitting (SIT), sitting with intermittent (every 30 min) walking (WALK; 2 min at 3.1 mph), or sitting with intermittent squats (SQUAT; 15 chair stands with calf raise)... Postprandial glucose and insulin did not differ across conditions following breakfast. After lunch, peak insulin concentration was lower in SQUAT (52 ± 27, P < 0.01) and WALK (62 ± 35, P < 0.05) compared with SIT (79 ± 43 μIU/mL)... 3-h insulin iAUC was reduced in SQUAT only (24% vs. SIT, P < 0.05). The 3-h insulin:glucose iAUC was reduced following lunch in both SQUAT (30%) and WALK (23%) compared with SIT (P < 0.05)." (abstract, results)
pubmedfull study (doi)
Sauna use is associated with lower all-cause mortality and lower cardiovascular-related mortality in individuals with type 2 diabetes.
"In addition to that, Jari took a cohort of individuals that actually were unhealthy. So they did have type 2 diabetes. And even in those cohorts, sauna use was associated with lower all-cause mortality, lower cardiovascular-related mortality as well." (said at 0:31:52)
The statement overstates the study population used in Dr. Jari Laukkanen's published research. Laukkanen and colleagues analyzed prospective data from the general population-based Kuopio Ischemic Heart Disease (KIHD) cohort (initially 2,315 middle-aged Finnish men, and later expanded to include women), not an exclusively diabetic cohort. While participants with type 2 diabetes were included as part of the general population and diabetes was adjusted for alongside other cardiovascular risk factors in multivariable models—where sauna bathing remained inversely associated with cardiovascular and all-cause mortality—the study was not conducted in a dedicated cohort restricted to individuals with type 2 diabetes.
- context: Association between sauna bathing and fatal cardiovascular and all-cause mortality events. (JAMA internal medicine 2015) · cited 288x in the literature
"We performed a prospective cohort study (Finnish Kuopio Ischemic Heart Disease Risk Factor Study) of a population-based sample of 2315 middle-aged (age range, 42-60 years) men from Eastern Finland... After adjustment for CVD risk factors, compared with men with 1 sauna bathing session per week, the hazard ratio of SCD was 0.78 (95% CI, 0.57-1.07) for 2 to 3 sauna bathing sessions per week and 0.37 (95% CI, 0.18-0.75) for 4 to 7 sauna bathing sessions per week (P for trend = .005). Similar associations were found with CHD, CVD, and all-cause mortality (P for trend ≤.005)." (abstract, methods and results)
pubmedfull study (doi)
Carrying one copy of a more active Hsp70 gene variant increases life expectancy by one year, while carrying two copies is associated with a two-year increase in life expectancy in humans.
"If those individuals have one copy from either mom or dad, that's associated with a one-year increase in life expectancy compared to people that don't have any of those copies. They're just making normal amounts of heat shock proteins. People that have two copies so they're homozygous, those individuals have a two-year increased life expectancy compared to people that don't have any copies." (said at 0:40:37)
A cohort study of nonagenarians born in 1905 (PMID 20388090) evaluated three polymorphisms in HSP70 genes (HSPA1A, HSPA1B, HSPA1L) and reported that female carriers of a specific three-SNP haplotype (G-C-T) lived, on average, about one year longer than non-carriers during follow-up. However, the study did not find that carrying one copy of an Hsp70 variant adds one year of life expectancy while two copies add two years of life expectancy across the general population. The effect reported was specific to a single haplotype in female nonagenarians, and the specific additive dose-response relationship (1 year for 1 copy, 2 years for 2 copies) claimed by the speaker is an oversimplification and exaggeration of the published association.
Short bursts of heat shock in worms and flies extend their life expectancy by approximately 20%.
"If you expose them to a really short burst burst of heat, it'll extend their life expectancy by like 20%. So, it seems to be an evolutionarily conserved mechanism as well." (said at 0:41:10)
While specific, highly controlled laboratory protocols of mild heat stress (heat hormesis) can extend the mean lifespan of model organisms like C. elegans and Drosophila by up to 10-20%, meta-analytic evaluation shows that heat shock does not universally or consistently increase longevity across studies. A systematic review and meta-analysis of 27 studies across 12 animal species found no overall measurable increase in longevity across animal models, noting that life extension via heat shock is highly conditional, constrained to extremely narrow parameter windows (temperature, duration, and frequency), and easily crosses the threshold into damaging or life-shortening exposure.
- contradicts: Life extension after heat shock exposure: assessing meta-analytic evidence for hormesis. (Ageing research reviews 2013) · cited 42x in the literature
"Contrary to our expectations, heat shock did not measurably increase longevity in the overall meta-analysis, although we observed much heterogeneity among studies. Thus, we explored the relative contributions of different experimental variables (i.e. moderators). Higher temperatures, longer durations of heat shock exposure, increased shock repeat and less time between repeat shocks, all decreased the likelihood of a life-extending effect, as would be expected when a hormetic response crosses the threshold to being a damaging exposure. We conclude that there is limited evidence that mild heat stress is a universal way of promoting longevity at the whole-organism level. Life extension via heat-induced hormesis is likely to be constrained to a narrow parameter window of experimental conditions." (abstract, results, passage verified)
pubmedfull study (doi)
Heat shock proteins remain activated for approximately 48 hours following heat exposure.
"By the way, the heat shock proteins stay activated for about 48 hours. So, the more frequently that you're exposing yourself to heat or exercise, which also raises your core body temperature, you're getting that heat shock protein response, right?" (said at 0:45:36)
Thermal stress triggers heat shock protein (HSP70) expression, and cellular kinetic studies show that elevated HSP70 expression can persist for up to 48 hours following heat exposure. However, applying a flat 48-hour timeframe to human sauna or exercise protocols overstates the evidence, as these kinetics vary based on heat duration, peak temperature, tissue type, and recovery conditions, and are primarily characterized in cell models.
In patients with major depressive disorder, whole-body cryotherapy at -236°F to -256°F for 2 minutes (5 times per week for 2 weeks) improved Hamilton depression scores by approximately 17 points.
"And so the people that did the 2 minutes at that -236°F five times a week for 2 weeks did have a pretty major anti sorry, antidepressant effect. In fact, on the Hamilton scale they improved by about 17 points, which is kind of phenomenal." (said at 0:49:44)
Clinical trials evaluating whole-body cryotherapy (-110°C to -160°C, or approximately -166°F to -256°F, for 10–15 sessions across 2–3 weeks) as an adjunct to pharmacotherapy for depressive disorders report significant reductions in depressive symptoms, but not a 17-point improvement. In these trials, the outcome measure used is the 17-item Hamilton Depression Rating Scale (HAM-D 17 / HDRS-17). The spoken claim appears to conflate the name of the 17-item scale (or baseline scores around 17 points) with the absolute magnitude of improvement.
Lactate produced during high-intensity vigorous exercise acts as a signaling molecule that prompts glucose transporters to translocate to the muscle cell surface.
"high-intensity vigorous exercise is the most important because it's causing an intense stress on your muscles, which are increasing glucose transporters to come up to the cell surface, bring glucose in better. Lactate is the molecule that's actually signaling to do that." (said at 1:05:01)
Exercise stimulates the translocation of glucose transporter 4 (GLUT4) from intracellular storage compartments to the muscle cell surface to facilitate glucose uptake independently of insulin. While recent preclinical research has identified lactate as a signaling metabolite that can promote GLUT4 translocation via GPR81 receptor activation and downstream RAC1 signaling, framing lactate as the primary or singular molecule signaling this process overstates its role. In exercise physiology, contraction-stimulated GLUT4 translocation is primarily driven by immediate intracellular signals, including calcium flux (via CaMKII), cellular energy depletion (via AMPK activation), and mechanical stress.
- supports: Exercise and insulin cause GLUT-4 translocation in human skeletal muscle. (The American journal of physiology 1999) · cited 191x in the literature
"These data demonstrate that two normal physiological conditions, moderate intensity exercise and physiological hyperinsulinemia approximately 56 microU/ml, cause GLUT-4 translocation and Akt phosphorylation in human skeletal muscle." (abstract, results, passage verified)
pubmedfull study (doi) - context: Cellular regulation of glucose uptake by glucose transporter GLUT4. (Advances in clinical chemistry 2014) · cited 71x in the literature
"Upon insulin stimulation (and contraction in muscle), GLUT4 translocates from these compartments to the cell surface where it transports glucose from the extracellular milieu into the cell." (abstract, results, passage verified)
pubmedfull study (doi) - partial: Lactate-activated GPR81/FARP1 signaling drives insulin-independent glucose uptake and meta… (Cell research 2026) · cited 1x in the literature
"Here, we identify L-lactate as an insulin-independent regulator of glucose uptake that mitigates hyperglycemia... Mechanistically, GPR81 recruits FARP1 to activate RAC1, promoting GLUT4 translocation independently of insulin signaling." (abstract, results)
pubmedfull study (doi)
Raising the red blood cell omega-3 index from a low level of 4% to an optimal level of 8% increases life expectancy by approximately 5 years.
"you can essentially increase someone's life expectancy by 5 years by bringing them from a low omega-3 index, which is 4%, to a high index, which is 8%." (said at 1:15:15)
The claim translates observational cohort modeling into a definitive causal effect of supplementation or dietary intervention. In observational prospective data from the Framingham Offspring Cohort, individuals in the highest red blood cell omega-3 index category (>6.8%) had a 34% lower risk of all-cause mortality compared to those in the lowest category (<4.2%), and predictive modeling indicated mortality hazard reductions roughly equivalent to ~4.7 to 5 years of modeled survival difference. However, these findings represent observational associations subject to residual confounding; interventional randomized trials have not demonstrated that raising the omega-3 index from 4% to 8% directly increases human life expectancy by 5 years.
Having a high omega-3 index is associated with a 90% lower risk of sudden cardiac death.
"it has a huge impact on 90% lower sudden cardiac death, 5-year increased life expectancy, a just a whole host of benefits" (said at 1:20:40)
Observational evidence has linked higher blood levels of long-chain omega-3 fatty acids to a substantial reduction in sudden cardiac death risk, but citing a 90% reduction slightly rounds up the landmark observational point estimate and overstates the overall randomized trial evidence. In the prospective nested case-control analysis from the Physicians' Health Study (Albert et al., 2002), men in the highest quartile of baseline whole-blood long-chain n-3 fatty acid levels had an 81% lower adjusted relative risk of sudden death compared to those in the lowest quartile (relative risk 0.19, 95% CI 0.05 to 0.71). While observational studies show large inverse associations, randomized trials of omega-3 supplementation have generally demonstrated more modest or mixed effects on cardiovascular outcomes and mortality.
Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.